Please Wait
Applying Filters...
menu
    • menu
    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Sonlicromanol

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Khondrion Receives FDA Clearance for Sonlicromanol Phase 3
    Khondrion Receives FDA Clearance for Sonlicromanol Phase 3

    14 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/14/2981036/0/en/Khondrion-receives-FDA-clearance-of-IND-application-for-pivotal-Phase-3-clinical-trial-of-sonlicromanol-for-the-treatment-of-primary-mitochondrial-disease.html

    GLOBENEWSWIRE
    14 Nov 2024
    Share Share
    Khondrion's Ph 2b Data on Sonlicromanol in Mitochondrial Disease
    Khondrion's Ph 2b Data on Sonlicromanol in Mitochondrial Disease

    07 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/07/2976519/0/en/Khondrion-announces-publication-in-Brain-of-integrated-Phase-2b-program-demonstrating-disease-modifying-potential-of-sonlicromanol-in-primary-mitochondrial-disease.html

    GLOBENEWSWIRE
    07 Nov 2024
    Share Share
    Khondrion announces grant of patents in the US and Europe for sonlicromanol
    Khondrion announces grant of patents in the US and Europe for sonlicromanol

    01 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/khondrion-announces-grant-of-patents-in-the-us-and-europe-for-its-lead-candidate-sonlicromanol-covering-the-anti-inflammatory-effect-on-mpges-1-301973246.html

    PR NEWSWIRE
    01 Nov 2023
    Share Share